HRP20110539T1 - PIRIDINO[3,4-b]PIRAZINONI - Google Patents

PIRIDINO[3,4-b]PIRAZINONI Download PDF

Info

Publication number: HRP20110539T1
Authority: HR; Croatia
Prior art keywords: group; substituents; propoxyethyl; alkyl; pyrido
Prior art date: 2006-04-21

Application number

HR20110539T

Other languages

English (en)

Croatian (hr)

Inventor

O. Hughes Robert

Simon Bell Andrew

Graham Brown David

Rhys Owen Dafydd

John Palmer Michael

Phillips Christopher

Louis Brown David

Marlene Fobian Yvette

Nicholas Freskos John

Edward Heasley Steven

Jon Jacobsen Eric

Michael Maddux Todd

Virgil Mischke Brent

Major Molyneaux John

Blair Moon Joseph

Joseph Jr. Rogier Donald

Brent Tollefson Michael

Keith Walker John

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-04-21

Filing date

2007-04-10

Publication date

2011-08-31

2007-04-10 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2011-08-31 Publication of HRP20110539T1 publication Critical patent/HRP20110539T1/hr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Separation Of Suspended Particles By Flocculating Agents (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Epoxy Compounds (AREA)

HR20110539T 2006-04-21 2007-04-10 PIRIDINO[3,4-b]PIRAZINONI HRP20110539T1 (hr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US79397106P	2006-04-21	2006-04-21
PCT/IB2007/001001 WO2007122466A1 (fr)	2006-04-21	2007-04-10	Pyridine[3,4-b]pyrazinones

Publications (1)

Publication Number	Publication Date
HRP20110539T1 true HRP20110539T1 (hr)	2011-08-31

Family

ID=38431249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20110539T HRP20110539T1 (hr)	2006-04-21	2007-04-10	PIRIDINO[3,4-b]PIRAZINONI

Country Status (41)

Country	Link
US (1)	US7902195B2 (fr)
EP (1)	EP2013208B1 (fr)
JP (1)	JP4436892B2 (fr)
KR (1)	KR101061328B1 (fr)
CN (1)	CN101454320B (fr)
AP (1)	AP2408A (fr)
AR (1)	AR060525A1 (fr)
AT (1)	ATE513831T1 (fr)
AU (1)	AU2007242555B2 (fr)
BR (1)	BRPI0710658A2 (fr)
CA (1)	CA2649775C (fr)
CR (1)	CR10327A (fr)
CU (1)	CU23777B7 (fr)
CY (1)	CY1111739T1 (fr)
DK (1)	DK2013208T3 (fr)
DO (1)	DOP2007000080A (fr)
EA (1)	EA014919B1 (fr)
EC (1)	ECSP088803A (fr)
ES (1)	ES2366239T3 (fr)
GT (1)	GT200700035A (fr)
HR (1)	HRP20110539T1 (fr)
IL (1)	IL194591A (fr)
MA (1)	MA30352B1 (fr)
ME (1)	MEP23808A (fr)
MX (1)	MX2008012456A (fr)
MY (1)	MY148583A (fr)
NL (1)	NL2000583C2 (fr)
NO (1)	NO20084129L (fr)
NZ (1)	NZ571540A (fr)
PA (1)	PA8724201A1 (fr)
PE (1)	PE20080192A1 (fr)
PL (1)	PL2013208T3 (fr)
RS (2)	RS20080484A (fr)
SI (1)	SI2013208T1 (fr)
SV (1)	SV2008003074A (fr)
TN (1)	TNSN08408A1 (fr)
TW (1)	TWI337609B (fr)
UA (1)	UA92637C2 (fr)
UY (1)	UY30291A1 (fr)
WO (1)	WO2007122466A1 (fr)
ZA (1)	ZA200808283B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RS20080484A (sr)	2006-04-21	2009-07-15	Pfizer Products Inc.,	PIRIDIN[3,4-b] PIRAZINONI
EP2101777B1 (fr)	2006-12-12	2015-05-20	Gilead Sciences, Inc.	Composition de traitement de l'hypertension pulmonaire
WO2009109341A1 (fr)	2008-03-05	2009-09-11	Merck Patent Gmbh	Dérivés de pyridopyrazinone comme stimulateurs de la sécrétion d’insuline, leurs procédés d’obtention et leur utilisation pour le traitement du diabète
TW201020233A (en) *	2008-10-09	2010-06-01	Kyorin Seiyaku Kk	Isoquinoline derivative, and pde inhibitor comprising same as active ingredient
MY177695A (en) *	2009-10-26	2020-09-23	Signal Pharm Llc	Methods of synthesis and purification of heteroaryl compounds
NZ610012A (en)	2010-10-15	2015-05-29	Gilead Sciences Inc	Compositions and methods of treating pulmonary hypertension
EP2691393B1 (fr)	2011-03-31	2016-09-14	Pfizer Inc	Nouvelles pyridones bicycliques
WO2012172449A1 (fr)	2011-06-13	2012-12-20	Pfizer Inc.	Lactames convenant comme inhibiteurs des bêta-sécrétases
ES2605565T3 (es)	2011-08-31	2017-03-15	Pfizer Inc	Compuestos de hexahidropirano [3,4-D][1,3]tiazin-2-amina
ES2585262T3 (es)	2012-05-04	2016-10-04	Pfizer Inc	Compuestos heterocíclicos de hexahidropiran[3,4-d][1,3]tiazin-2-amina sustituidos como inhibidores de PPA, BACE1 y BACE2
CA2882389A1 (fr)	2012-09-20	2014-03-27	Pfizer Inc.	Composes d'hexahydropyrano[3,4-d][1,3]thiazine-2-amine alkyl-substitues
UA110688C2 (uk)	2012-09-21	2016-01-25	Пфайзер Інк.	Біциклічні піридинони
WO2014091352A1 (fr)	2012-12-11	2014-06-19	Pfizer Inc.	Composés d'hexahydropyrano [3,4-d][1,3]thiazin-2-amine en tant qu'inhibiteurs de bace1
CA2893333C (fr)	2012-12-19	2017-10-24	Pfizer Inc.	Composes hexahydropyrano[3,4-d][1,3]thiazin-2-amine substitues carbocycliques et heterocycliques
WO2014125394A1 (fr)	2013-02-13	2014-08-21	Pfizer Inc.	Composés hexahydropyrano [3,4-d][1,3] thiazin-2-amine substitués par un hétéroaryle
US9233981B1 (en)	2013-02-15	2016-01-12	Pfizer Inc.	Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
CN105121439A (zh)	2013-02-19	2015-12-02	辉瑞公司	作为pde4亚型抑制剂用于治疗cns和其他病症的氮杂苯并咪唑化合物
ES2742078T3 (es)	2013-10-04	2020-02-13	Pfizer	Piridonas bicíclicas novedosas como moduladores de gamma-secretasa
JO3466B1 (ar) *	2013-12-20	2020-07-05	Takeda Pharmaceuticals Co	مواد ضابطة لتترا هيدرو بيريدوبيرازينات من gpr6
DK3126361T3 (da)	2014-04-01	2020-01-02	Pfizer	Chromen og 1,1a,2,7b-tetrahydrocyclopropa[c]chromen- pyridopyrazindioner som gamma-sekretase-modulatorer
PE20170327A1 (es)	2014-04-10	2017-04-21	Pfizer	2-AMINO-6-METIL-4,4a,5,6-TETRAHIDROPIRANO[3,4d] [1,3] TIAZIN-8a(8H)-IL-1,3-TIAZOL-4-ILAMIDAS
WO2016012896A1 (fr)	2014-07-24	2016-01-28	Pfizer Inc.	Composés de pyrazolopyrimidine
PL3177624T3 (pl)	2014-08-06	2019-09-30	Pfizer Inc.	Związki imidazopirydazynowe
MX368391B (es)	2015-02-03	2019-09-30	Pfizer	Ciclopropabenzofuranil-piridopirazindionas novedosas.
EP3766885B1 (fr)	2015-06-17	2022-05-25	Pfizer Inc.	Composés tricycliques comme inhibiteurs de la phosphodiesterase
WO2017051276A1 (fr)	2015-09-24	2017-03-30	Pfizer Inc.	N-[2-(2-amino-6,6-disubstitués-4,4a,5,6-tétrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl)-1,3-thiazol-4-yl]amides
WO2017051294A1 (fr)	2015-09-24	2017-03-30	Pfizer Inc.	N-[2-(3-amino-2,5-diméthyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides utiles comme inhibiteurs de bace
EP3353182A1 (fr)	2015-09-24	2018-08-01	Pfizer Inc	Dérivés de tétrahydropyrano[3,4-d][1,3]oxazine et leur utilisation en tant qu'inhibiteurs de bace
SG11201806383TA (en)	2016-02-23	2018-09-27	Pfizer	6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
WO2018002760A1 (fr)	2016-07-01	2018-01-04	Pfizer Inc.	Dérivés de 5,7-dihydro-pyrrolo-pyridine pour le traitement de maladies neurologiques et neurodégénératives
BR112019026955A2 (pt)	2017-06-22	2020-06-30	Pfizer Inc.	derivados de di-hidro-pirrolo-piridina
CN111182898B (zh) *	2017-06-28	2024-04-16	Ptc医疗公司	用于治疗亨廷顿氏病的方法
EP4219464A1 (fr)	2018-03-23	2023-08-02	Pfizer Inc.	Pipérazine azaspiro derivaves
EP4297868A4 (fr)	2021-02-23	2025-01-08	Hoth Therapeutics, Inc.	Utilisation d'aprépitant pour le traitement de la maladie d'alzheimer
WO2024118524A1 (fr)	2022-11-28	2024-06-06	Cerevel Therapeutics, Llc	Composés d'azaindole et leur utilisation en tant qu'inhibiteurs de phosphodiestérase
WO2025145091A1 (fr)	2023-12-29	2025-07-03	Pfizer Inc.	Formes cristallines d'un modulateur muscarinique m4 du récepteur et méthodes de traitement de maladies
WO2025160132A1 (fr) *	2024-01-23	2025-07-31	Maplight Therapeutics, Inc.	Agonistes inverses de gpr6

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1361652A (fr)	1963-06-21	1964-05-22	Ciba Geigy	Procédé de préparation de diazines, entre autres de la 2-méthyl-6-hydroxy-7-morpholino-ptéridine
ATE194985T1 (de)	1990-11-06	2000-08-15	Yamanouchi Pharma Co Ltd	Kondensiertes pyrazinderivat
TW274550B (fr)	1992-09-26	1996-04-21	Hoechst Ag
JP2000154139A (ja)	1998-09-16	2000-06-06	Kyowa Hakko Kogyo Co Ltd	縮環ピラジン誘導体
US6369056B1 (en)	1999-05-04	2002-04-09	American Home Products Corporation	Cyclic urea and cyclic amide derivatives
US6465465B1 (en) *	2000-03-14	2002-10-15	Arzneimittelwerk Dresden Gmbh	Process for the treatment of erectile dysfunction and product therefor
MXPA03007623A (es) *	2001-02-26	2003-12-04	Tanabe Seiyaku Co	Derivado de piridopirimidina o naftiridina.
WO2002076954A1 (fr)	2001-03-23	2002-10-03	Smithkline Beecham Corporation	Composes utiles en tant qu'inhibiteurs de kinase pour le traitement de maladies hyperproliferantes
US20030114469A1 (en) *	2001-09-27	2003-06-19	Cohen David Saul	Combinations
US7067658B2 (en)	2002-09-30	2006-06-27	Bristol-Myers Squibb Company	Pyridino and pyrimidino pyrazinones
WO2005040337A2 (fr)	2003-05-20	2005-05-06	The Regents Of The University Of California	Procedes permettant de lier des agents a des plaques $g(b)-amyloides
CA2529196A1 (fr)	2003-06-26	2005-02-17	Merck & Co., Inc.	Antagonistes du recepteur du cgrp de
DE102004033670A1 (de)	2004-07-09	2006-02-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
CA2593005A1 (fr)	2005-01-03	2006-07-13	Myriad Genetics Inc.	Composes pharmaceutiques constituant des activateurs de caspases et des inducteurs d'apoptose et utilisation de ces composes
WO2006126082A2 (fr) *	2005-05-24	2006-11-30	Pharmacia & Upjohn Company Llc	Pyridine [3,4-b] pyrazinones
EP1940805A4 (fr)	2005-08-26	2009-11-11	Methylgene Inc	Inhibiteurs d'analogues de benzodiazepine et de benzopiperazine de l'histone deacetylase
WO2007112347A1 (fr)	2006-03-28	2007-10-04	Takeda Pharmaceutical Company Limited	Inhibiteurs de la dipeptidyl peptidase
RS20080484A (sr)	2006-04-21	2009-07-15	Pfizer Products Inc.,	PIRIDIN[3,4-b] PIRAZINONI

2007
- 2007-04-10 RS RSP-2008/0484A patent/RS20080484A/sr unknown
- 2007-04-10 EP EP07734320A patent/EP2013208B1/fr active Active
- 2007-04-10 AU AU2007242555A patent/AU2007242555B2/en not_active Ceased
- 2007-04-10 MY MYPI20084131A patent/MY148583A/en unknown
- 2007-04-10 ES ES07734320T patent/ES2366239T3/es active Active
- 2007-04-10 PL PL07734320T patent/PL2013208T3/pl unknown
- 2007-04-10 AT AT07734320T patent/ATE513831T1/de active
- 2007-04-10 EA EA200801998A patent/EA014919B1/ru not_active IP Right Cessation
- 2007-04-10 WO PCT/IB2007/001001 patent/WO2007122466A1/fr not_active Ceased
- 2007-04-10 JP JP2009505983A patent/JP4436892B2/ja not_active Expired - Fee Related
- 2007-04-10 DK DK07734320.0T patent/DK2013208T3/da active
- 2007-04-10 ME MEP-238/08A patent/MEP23808A/xx unknown
- 2007-04-10 AP AP2008004640A patent/AP2408A/xx active
- 2007-04-10 SI SI200730675T patent/SI2013208T1/sl unknown
- 2007-04-10 MX MX2008012456A patent/MX2008012456A/es active IP Right Grant
- 2007-04-10 HR HR20110539T patent/HRP20110539T1/hr unknown
- 2007-04-10 RS RS20110363A patent/RS51885B/sr unknown
- 2007-04-10 BR BRPI0710658-0A patent/BRPI0710658A2/pt not_active IP Right Cessation
- 2007-04-10 CN CN2007800198932A patent/CN101454320B/zh not_active Expired - Fee Related
- 2007-04-10 CA CA2649775A patent/CA2649775C/fr not_active Expired - Fee Related
- 2007-04-10 KR KR1020087028465A patent/KR101061328B1/ko not_active Expired - Fee Related
- 2007-04-10 NZ NZ571540A patent/NZ571540A/en not_active IP Right Cessation
- 2007-04-11 NL NL2000583A patent/NL2000583C2/nl not_active IP Right Cessation
- 2007-04-18 UY UY30291A patent/UY30291A1/es not_active Application Discontinuation
- 2007-04-18 AR ARP070101657A patent/AR060525A1/es not_active Application Discontinuation
- 2007-04-19 GT GT200700035A patent/GT200700035A/es unknown
- 2007-04-19 PE PE2007000483A patent/PE20080192A1/es not_active Application Discontinuation
- 2007-04-20 DO DO2007000080A patent/DOP2007000080A/es unknown
- 2007-04-20 PA PA20078724201A patent/PA8724201A1/es unknown
- 2007-04-20 US US11/737,966 patent/US7902195B2/en not_active Expired - Fee Related
- 2007-04-20 TW TW096114037A patent/TWI337609B/zh not_active IP Right Cessation
- 2007-10-04 UA UAA200812397A patent/UA92637C2/ru unknown
2008
- 2008-09-29 NO NO20084129A patent/NO20084129L/no not_active Application Discontinuation
- 2008-09-29 ZA ZA200808283A patent/ZA200808283B/xx unknown
- 2008-09-30 CR CR10327A patent/CR10327A/es unknown
- 2008-10-07 IL IL194591A patent/IL194591A/en not_active IP Right Cessation
- 2008-10-08 EC EC2008008803A patent/ECSP088803A/es unknown
- 2008-10-17 CU CU20080194A patent/CU23777B7/es active IP Right Grant
- 2008-10-17 TN TNP2008000408A patent/TNSN08408A1/fr unknown
- 2008-10-21 MA MA31321A patent/MA30352B1/fr unknown
- 2008-10-21 SV SV2008003074A patent/SV2008003074A/es unknown
2011
- 2011-07-25 CY CY20111100731T patent/CY1111739T1/el unknown

Also Published As

Publication number	Publication date
EP2013208B1 (fr)	2011-06-22
TWI337609B (en)	2011-02-21
IL194591A (en)	2012-07-31
PA8724201A1 (es)	2009-08-26
CA2649775A1 (fr)	2007-11-01
PE20080192A1 (es)	2008-03-01
NL2000583C2 (nl)	2007-12-14
UA92637C2 (en)	2010-11-25
GT200700035A (es)	2008-02-05
KR101061328B1 (ko)	2011-08-31
CR10327A (es)	2008-10-21
DK2013208T3 (da)	2011-08-15
MX2008012456A (es)	2008-10-10
AP2408A (en)	2012-05-30
CN101454320B (zh)	2012-12-19
NZ571540A (en)	2010-10-29
CN101454320A (zh)	2009-06-10
CA2649775C (fr)	2011-05-31
CU20080194A7 (es)	2011-03-21
TW200808794A (en)	2008-02-16
DOP2007000080A (es)	2007-11-15
CU23777B7 (es)	2012-02-15
SV2008003074A (es)	2010-01-12
UY30291A1 (es)	2007-11-30
AP2008004640A0 (en)	2008-10-31
NO20084129L (no)	2008-10-29
ES2366239T3 (es)	2011-10-18
KR20080110930A (ko)	2008-12-19
AR060525A1 (es)	2008-06-25
ZA200808283B (en)	2009-11-25
US20070249615A1 (en)	2007-10-25
RS20080484A (sr)	2009-07-15
NL2000583A1 (nl)	2007-10-23
MY148583A (en)	2013-04-30
US7902195B2 (en)	2011-03-08
WO2007122466A1 (fr)	2007-11-01
CY1111739T1 (el)	2015-10-07
MA30352B1 (fr)	2009-04-01
EA200801998A1 (ru)	2009-04-28
PL2013208T3 (pl)	2011-10-31
EP2013208A1 (fr)	2009-01-14
RS51885B (sr)	2012-02-29
SI2013208T1 (sl)	2011-09-30
ATE513831T1 (de)	2011-07-15
JP2009534368A (ja)	2009-09-24
JP4436892B2 (ja)	2010-03-24
AU2007242555B2 (en)	2010-12-16
MEP23808A (en)	2010-06-10
EA014919B1 (ru)	2011-04-29
BRPI0710658A2 (pt)	2011-08-16
TNSN08408A1 (fr)	2010-04-14
AU2007242555A1 (en)	2007-11-01
ECSP088803A (es)	2008-11-27
HK1133875A1 (en)	2010-04-09

Publication	Publication Date	Title
HRP20110539T1 (hr)	2011-08-31	PIRIDINO[3,4-b]PIRAZINONI
JP2009534368A5 (fr)	2009-11-05
ES2697174T3 (es)	2019-01-22	Compuestos para tratar atrofia muscular espinal
US9428506B2 (en)	2016-08-30	Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
RU2728787C2 (ru)	2020-07-31	Органические соединения
HRP20200624T1 (hr)	2020-07-10	Derivati 2-(2,4,5-supstituiranog-anilino)pirimidina kao modulatori egfr korisni za liječenje raka
KR101720824B1 (ko)	2017-03-28	카테콜 ｏ-메틸 트랜스퍼라제의 억제제 및 정신병적 장애의 치료에서의 그의 용도
CN112409363B (zh)	2023-11-14	用于治疗认知损害的苯并二氮杂䓬衍生物、组合物和方法
WO2004087677A3 (fr)	2004-12-16	Pyrimidinones substituees
JP2019510039A (ja)	2019-04-11	新規組成物および方法
CN101448829A (zh)	2009-06-03	4-氨基-吡啶并[3,2-e]吡嗪类，其作为磷酸二酯酶10的抑制剂的用途以及制备它们的方法
JP2011520832A5 (fr)	2012-07-05
WO2015154030A1 (fr)	2015-10-08	Composés organiques
CN109641898A (zh)	2019-04-16	用于治疗神经和神经退行性疾病的5,7-二氢-吡咯并-吡啶衍生物
WO2017165755A1 (fr)	2017-09-28	Composés organiques
HRP20160647T1 (hr)	2016-07-01	Novi heterociklički derivati i njihova uporaba u liječenju neuroloških poremećaja
RU2003134544A (ru)	2005-03-27	Амиды антраниловой кислоты, способы их получения, их применение в качестве антиаритмических средств, а также содержащие их фармацевтические композиции
JP2014503544A5 (fr)	2015-01-15
ATE370138T1 (de)	2007-09-15	Neue imidazopyridine und ihre verwendung
AR053011A1 (es)	2007-04-18	Compuestos de heteroarilo como inhibidores del receptor p2y1, composiciones farmaceuticas que los contienen y su uso en la manufactura de un medicamento para el tratamiento de un trastorno tromboembolico
EA200600811A1 (ru)	2006-10-27	НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
RU2016110483A (ru)	2017-10-04	Производные пирролопиридина или пиразолопиридина
JP6285610B2 (ja)	2018-02-28	アゼチジニルオキシフェニルピロリジン化合物
RU2019125177A (ru)	2021-02-15	Новые производные амино-имидазопиридина в качестве ингибиторов янус-киназы и их фармацевтическое применение
KR20250114139A (ko)	2025-07-28	치환된 테트라하이드로피롤로-피리디논 화합물 및 의학적 병태 치료에서의 이의 용도